Provided by Tiger Trade Technology Pte. Ltd.

Galectin Therapeutics

3.97
+0.33009.07%
Volume:108.18K
Turnover:412.25K
Market Cap:400.97M
PE:-9.23
High:3.97
Open:3.64
Low:3.64
Close:3.64
52wk High:7.13
52wk Low:2.03
Shares:101.00M
Float Shares:48.17M
Volume Ratio:0.49
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4302
EPS(LYR):-0.4847
ROE:-3727.94%
ROA:-64.18%
PB:-2.88
PE(LYR):-8.19

Loading ...

Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 01, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 21, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 09, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 19, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Major Issues Report

8-K - Current report
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2021

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Dec 03, 2020

Major Issues Report

8-K - Current report